PeptiGrowth Inc. Introduces a New Synthetic Peptide
PeptiGrowth Inc., based in Chiyoda-ku, Tokyo, proudly announces the successful development of a pioneering synthetic peptide known as "KGF alternative peptide (FGFR2b agonist)." This innovative peptide has been designed to mimic the function of recombinant keratinocyte growth factor (KGF) while addressing common complications associated with traditional growth factors.
About KGF Alternative Peptide (FGFR2b Agonist)
The KGF alternative peptide, coded PG-012, is a dimeric peptide. Its unique structure of cyclic peptides allows it to bind specifically to FGFR2b, activating similar biological responses as KGF. Comparative studies have shown that this peptide triggers signal activation at lower concentrations, making it a promising candidate for future therapeutic applications.
Mechanism of Action
The mechanism through which PG-012 operates involves its effective interaction with FGFR2b, akin to KGF, activating pathways crucial for cellular growth. The activation of the ERK signaling cascade has been demonstrated, suggesting the potential for enhanced proliferation of specific cells.
Applications in Regenerative Medicine
This synthesized peptide is anticipated to be beneficial in regenerative therapies, particularly for the differentiation and proliferation of epidermal cells and those derived from endodermal sources. Examples include alveolar epithelial cells and hepatocytes which are critical in various therapeutic contexts.
Product Information
The KGF alternative peptide (PG-012) comes in a lyophilized form. It is characterized by high purity levels of 95% as assessed by HPLC. Available in sizes of 10 ?g, 100 ?g, and 1 mg, this product is designed for research purposes and adheres to animal component-free standards, making it a suitable option for xeno-free cell culture applications.
Future Developments at PeptiGrowth
PeptiGrowth is dedicated to advancing peptide technology. They have successfully launched 12 products targeting various cytokines and growth factors with plans to introduce additional alternative peptides such as PDGF-AA and IL-15 by late 2025. The aim is to continuously improve research outcomes in the field of regenerative medicine.
Contact PeptiGrowth
For inquiries or purchase requests, individuals and organizations may reach out to PeptiGrowth Inc. directly. Their commitment to quality and innovation is evident, and they encourage collaboration to enhance the future of regenerative therapies.
Frequently Asked Questions
What is the KGF alternative peptide?
The KGF alternative peptide, known as PG-012, is a synthetic peptide designed to replicate the functions of keratinocyte growth factor.
How does PG-012 work?
PG-012 activates FGFR2b, leading to cellular signaling similar to that of KGF, promoting cell proliferation.
What are the potential applications of this peptide?
This peptide may be used in regenerative medicine for applications involving epidermal cells and endodermal derivatives.
What is the purity level of PG-012?
The product boasts a purity of 95% as measured by HPLC, ensuring high quality for research applications.
How can I purchase products from PeptiGrowth?
Interested parties should contact PeptiGrowth directly for inquiries related to purchasing products and for bulk order details for GMP compliant options.
